US Stock MarketDetailed Quotes

TOVX Theriva Biologics

Watchlist

1.3400
+0.0600+4.69%

Close Nov 27 16:00 ET

1.3200
-0.0200-1.49%

Post 20:01 ET

3.73MMarket Cap-41P/E (TTM)

Theriva Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

19.39%5.04M

-24.05%4.42M

4.13%5.39M

-0.70%21.43M

-15.03%6.22M

-15.40%4.22M

15.80%5.82M

21.78%5.18M

51.19%21.58M

38.97%7.32M

Selling and administrative expenses

985.85%2.3M

-45.40%1.47M

-12.18%1.93M

-27.77%7.12M

-52.40%2.02M

-91.23%212K

74.37%2.69M

32.99%2.2M

52.27%9.86M

70.80%4.25M

-General and administrative expense

985.85%2.3M

-45.40%1.47M

-12.18%1.93M

-27.77%7.12M

-52.40%2.02M

-91.23%212K

74.37%2.69M

32.99%2.2M

52.27%9.86M

70.80%4.25M

Research and development costs

-31.75%2.73M

-5.75%2.95M

16.19%3.46M

22.08%14.31M

36.63%4.2M

55.88%4.01M

-10.10%3.13M

14.63%2.98M

50.29%11.72M

10.51%3.07M

Operating profit

-19.39%-5.04M

24.05%-4.42M

-4.13%-5.39M

0.70%-21.43M

15.03%-6.22M

15.40%-4.22M

-15.80%-5.82M

-21.78%-5.18M

-51.19%-21.58M

-38.97%-7.32M

Net non-operating interest income expense

-58.64%158K

-54.59%173K

-37.36%228K

181.05%1.44M

-0.95%312K

124.71%382K

1,365.38%381K

18,100.00%364K

8,433.33%512K

15,650.00%315K

Non-operating interest income

-58.64%158K

-54.59%173K

-37.36%228K

181.05%1.44M

-0.95%312K

124.71%382K

1,365.38%381K

18,100.00%364K

8,433.33%512K

15,650.00%315K

Other net income (expense)

-47,566.67%-2.85M

-101,625.00%-4.07M

-116.67%-1K

107.32%3K

-300.00%-4K

166.67%6K

55.56%-4K

126.09%6K

-41K

-1K

Gain on sale of security

-50.00%3K

75.00%-1K

-116.67%-1K

107.32%3K

-300.00%-4K

166.67%6K

55.56%-4K

126.09%6K

---41K

---1K

Special income (charges)

---2.85M

---4.07M

----

--0

----

-Less：Restructuring and merger&acquisition

--1.33M

----

--0

----

-Less:Impairment of capital assets

--1.53M

--4.07M

----

--0

----

Income before tax

-101.72%-7.73M

-52.78%-8.32M

-7.43%-5.17M

5.31%-19.99M

15.62%-5.91M

20.62%-3.83M

-8.66%-5.44M

-12.52%-4.81M

-47.95%-21.11M

-33.06%-7M

Income tax

-15.09%-1.64M

24.01%-424K

-57.31%-527K

32.52%-359K

-330K

-1.43M

-558K

Net income

-133.91%-7.73M

-63.57%-8.32M

-15.34%-5.17M

6.79%-18.35M

14.90%-5.49M

26.44%-3.3M

-13.56%-5.08M

-4.80%-4.48M

-37.97%-19.69M

-22.46%-6.45M

Net income continuous Operations

-133.91%-7.73M

-63.57%-8.32M

-15.34%-5.17M

6.79%-18.35M

14.90%-5.49M

26.44%-3.3M

-13.56%-5.08M

-4.80%-4.48M

-37.97%-19.69M

-22.46%-6.45M

Minority interest income

Net income attributable to the parent company

-133.91%-7.73M

-63.57%-8.32M

-15.34%-5.17M

6.79%-18.35M

14.90%-5.49M

26.44%-3.3M

-13.56%-5.08M

-4.80%-4.48M

-37.98%-19.69M

-22.46%-6.45M

Preferred stock dividends

Other preferred stock dividends

-95.41%340K

Net income attributable to common stockholders

-133.91%-7.73M

-63.57%-8.32M

-15.34%-5.17M

8.37%-18.35M

14.90%-5.49M

31.61%-3.3M

-13.56%-5.08M

-4.80%-4.48M

13.64%-20.03M

-22.46%-6.45M

Basic earnings per share

-40.41%-6.81

-26.47%-10.75

0.00%-7.5

12.98%-28.5

26.18%-8.12

35.33%-4.85

-21.43%-8.5

3.23%-7.5

31.05%-32.75

-12.82%-11

Diluted earnings per share

-40.41%-6.81

-26.47%-10.75

0.00%-7.5

12.98%-28.5

26.18%-8.12

35.33%-4.85

-21.43%-8.5

3.23%-7.5

31.05%-32.75

-12.82%-11

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	19.39%5.04M	-24.05%4.42M	4.13%5.39M	-0.70%21.43M	-15.03%6.22M	-15.40%4.22M	15.80%5.82M	21.78%5.18M	51.19%21.58M	38.97%7.32M
Selling and administrative expenses	985.85%2.3M	-45.40%1.47M	-12.18%1.93M	-27.77%7.12M	-52.40%2.02M	-91.23%212K	74.37%2.69M	32.99%2.2M	52.27%9.86M	70.80%4.25M
-General and administrative expense	985.85%2.3M	-45.40%1.47M	-12.18%1.93M	-27.77%7.12M	-52.40%2.02M	-91.23%212K	74.37%2.69M	32.99%2.2M	52.27%9.86M	70.80%4.25M
Research and development costs	-31.75%2.73M	-5.75%2.95M	16.19%3.46M	22.08%14.31M	36.63%4.2M	55.88%4.01M	-10.10%3.13M	14.63%2.98M	50.29%11.72M	10.51%3.07M
Operating profit	-19.39%-5.04M	24.05%-4.42M	-4.13%-5.39M	0.70%-21.43M	15.03%-6.22M	15.40%-4.22M	-15.80%-5.82M	-21.78%-5.18M	-51.19%-21.58M	-38.97%-7.32M
Net non-operating interest income expense	-58.64%158K	-54.59%173K	-37.36%228K	181.05%1.44M	-0.95%312K	124.71%382K	1,365.38%381K	18,100.00%364K	8,433.33%512K	15,650.00%315K
Non-operating interest income	-58.64%158K	-54.59%173K	-37.36%228K	181.05%1.44M	-0.95%312K	124.71%382K	1,365.38%381K	18,100.00%364K	8,433.33%512K	15,650.00%315K
Other net income (expense)	-47,566.67%-2.85M	-101,625.00%-4.07M	-116.67%-1K	107.32%3K	-300.00%-4K	166.67%6K	55.56%-4K	126.09%6K	-41K	-1K
Gain on sale of security	-50.00%3K	75.00%-1K	-116.67%-1K	107.32%3K	-300.00%-4K	166.67%6K	55.56%-4K	126.09%6K	---41K	---1K
Special income (charges)	---2.85M	---4.07M	----	----	----	--0	--0	----	----	----
-Less：Restructuring and merger&acquisition	--1.33M	----	----	----	----	--0	----	----	----	----
-Less:Impairment of capital assets	--1.53M	--4.07M	----	----	----	--0	--0	----	----	----
Income before tax	-101.72%-7.73M	-52.78%-8.32M	-7.43%-5.17M	5.31%-19.99M	15.62%-5.91M	20.62%-3.83M	-8.66%-5.44M	-12.52%-4.81M	-47.95%-21.11M	-33.06%-7M
Income tax	0	0	0	-15.09%-1.64M	24.01%-424K	-57.31%-527K	32.52%-359K	-330K	-1.43M	-558K
Net income	-133.91%-7.73M	-63.57%-8.32M	-15.34%-5.17M	6.79%-18.35M	14.90%-5.49M	26.44%-3.3M	-13.56%-5.08M	-4.80%-4.48M	-37.97%-19.69M	-22.46%-6.45M
Net income continuous Operations	-133.91%-7.73M	-63.57%-8.32M	-15.34%-5.17M	6.79%-18.35M	14.90%-5.49M	26.44%-3.3M	-13.56%-5.08M	-4.80%-4.48M	-37.97%-19.69M	-22.46%-6.45M
Minority interest income
Net income attributable to the parent company	-133.91%-7.73M	-63.57%-8.32M	-15.34%-5.17M	6.79%-18.35M	14.90%-5.49M	26.44%-3.3M	-13.56%-5.08M	-4.80%-4.48M	-37.98%-19.69M	-22.46%-6.45M
Preferred stock dividends
Other preferred stock dividends				0					-95.41%340K	0
Net income attributable to common stockholders	-133.91%-7.73M	-63.57%-8.32M	-15.34%-5.17M	8.37%-18.35M	14.90%-5.49M	31.61%-3.3M	-13.56%-5.08M	-4.80%-4.48M	13.64%-20.03M	-22.46%-6.45M
Basic earnings per share	-40.41%-6.81	-26.47%-10.75	0.00%-7.5	12.98%-28.5	26.18%-8.12	35.33%-4.85	-21.43%-8.5	3.23%-7.5	31.05%-32.75	-12.82%-11
Diluted earnings per share	-40.41%-6.81	-26.47%-10.75	0.00%-7.5	12.98%-28.5	26.18%-8.12	35.33%-4.85	-21.43%-8.5	3.23%-7.5	31.05%-32.75	-12.82%-11
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data